ACM
PRTK

Aquatic Capital Management’s Paratek Pharmaceuticals, Inc. PRTK Stock Holding History

Aquatic Capital Management’s Portfolio PRTK Stock Details PRTK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		– Sell
-3,000
Closed -$9K – 1675
2022
Q1 		$9K Buy
+3,000
New +$11.3K 0.01% 700

Other funds holding PRTK

ACM
AIGH Capital Management Baltimore, Maryland $733M AUM 327.32% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
OFM
Omega Fund Management Boston, Massachusetts $163M AUM 107.06% 1-Year Est. Return
GAI
General American Investors New York $1.52B AUM 37.94% 1-Year Est. Return
RSCM
Rock Springs Capital Management Baltimore, Maryland $1.7B AUM 93.03% 1-Year Est. Return
BC
Bruce & Co Chicago, Illinois $350M AUM 33.5% 1-Year Est. Return
WVP
Worth Venture Partners Fort Lee, New Jersey $31.6M AUM 28.5% 1-Year Est. Return
A
Abingworth London, United Kingdom $307M AUM 93.47% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
FIG
Fortress Investment Group New York $394M AUM 22.99% 1-Year Est. Return

Aquatic Capital Management's PRTK Position: Q2 2022 in Review

Aquatic Capital Management sold out of Paratek Pharmaceuticals, Inc. (PRTK) in Q2 2022, closing a stake of 3,000 shares — an estimated $9K sold.

Aquatic Capital Management first reported a position in PRTK in Q1 2022 and held it in 1 quarter. The position peaked at $9K in Q1 2022. 84 funds tracked by Wall St. Rank hold PRTK as of Q2 2022.

  • Aquatic Capital Management reported no remaining Paratek Pharmaceuticals, Inc. position as of Q2 2022 after selling out during the quarter.
  • Aquatic Capital Management sold 3,000 Paratek Pharmaceuticals, Inc. shares in Q2 2022, an estimated $9K.
  • Aquatic Capital Management first reported a position in Paratek Pharmaceuticals, Inc. in Q1 2022 and held it in 1 quarter.
  • Aquatic Capital Management's Paratek Pharmaceuticals, Inc. position peaked at $9K in Q1 2022.
  • 84 funds tracked by Wall St. Rank held Paratek Pharmaceuticals, Inc. as of Q2 2022.

Based on Aquatic Capital Management's 13F filing for Q2 2022, filed 15 Aug 2022.